CT Cardiac Function Analysis and Cardiac Calcium Scoring Applications Designed for Visualization System

New analysis imaging applications enhance the productivity and diagnostic capability of physicians when evaluating patients' heart health. Both the cardiac function analysis and calcium scoring applications can be accessed throughout the enterprise on a thin-client system to provide physicians with improved efficiency and real-time collaboration when evaluating results from a computed tomography (CT) cardiac scan.

Ziosoft, Inc. (Redwood, CA, USA), a developer of advanced visualization and analysis software for medical imaging, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market two additional applications for use with the Ziostation thin-client system.

The calcium scoring application is used by physicians to help determine whether a patient may be at increased risk for coronary artery disease. Ziosoft's calcium scoring application features valuable tools for the clinician such as concurrent reading of the calcium analysis adjacent to the original data set, which allows for efficient and precise analysis of data.

The cardiac function application enables physicians to conduct a cardiac functional assessment and includes Ziosoft's unique tools such as automatic left ventricle segmentation, peak-filling rate (PFR), and peak-ejection rate (PER) in addition to the standard functional assessment calculations. The cardiac function application also includes the capability to automatically generate "bulls-eye" maps and a time volume graph to aid in the physician's evaluation.

According to the U.S. National Center for Health Statistics (NCHS; Atlanta, GA, USA) every year since 1900, except 1918, cardiovascular disease accounted for more deaths than any other single cause or group of causes of death in the United States. These new applications from Ziosoft will contribute to more efficient interpretation and improved communication of test results, leading to enhanced quality of care for patients.

"We are proud of our long history of developing software applications which aid physicians in evaluating diseases" said Kazuhiko Matsumoto, Ziosoft's chief executive officer. "These latest applications will be added to Ziosoft's suite of applications for a robust cardiac tool set for the market."

Ziosoft is a developer of networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Ziosoft is the leading independent advanced visualization company in Japan with over 1,800 installed systems. Ziosoft is focused on providing intelligent and intuitive clinical tools across the enterprise.

Related Links:
Ziosoft